175 related articles for article (PubMed ID: 33926462)
21. Determinants of post-malarial anemia in African children treated with parenteral artesunate.
Scheu K; Adegnika AA; Addo MM; Ansong D; Cramer JP; Fürst S; Kremsner PG; Kurth F; Jacobs T; May J; Ramharter M; Sylverken J; Vinnemeier CD; Agbenyega T; Rolling T
Sci Rep; 2019 Dec; 9(1):18134. PubMed ID: 31792345
[TBL] [Abstract][Full Text] [Related]
22. Delayed Hemolytic Anemia after Treatment with Artesunate: Case Report and Literature Review.
Salehi M; Masoumi-Asl H; Assarian M; Khoshnam-Rad N; Haghi AM; Nikbakht M; Khalili H
Curr Drug Saf; 2019; 14(1):60-66. PubMed ID: 30411691
[TBL] [Abstract][Full Text] [Related]
23. Treatment for Severe Malaria: Post-Artesunate Delayed Haemolysis and Neutropenia.
Martino M; Liberati C; Bua B; Barbieri E; Costenaro P; Di Chiara C; Giaquinto C; De Canale E; Rampon O; Donà D
Healthcare (Basel); 2022 Feb; 10(3):. PubMed ID: 35326891
[TBL] [Abstract][Full Text] [Related]
24. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
[TBL] [Abstract][Full Text] [Related]
25. Delayed haemolysis secondary to treatment of severe malaria with intravenous artesunate: Report on the experience of a referral centre for tropical infections in Spain.
Aldámiz-Echevarría Lois T; López-Polín A; Norman FF; Monge-Maillo B; López-Vélez R; Perez-Molina JA
Travel Med Infect Dis; 2017; 15():52-56. PubMed ID: 27818359
[TBL] [Abstract][Full Text] [Related]
26. Post-artesunate delayed haemolysis in severe imported Plasmodium falciparum malaria.
Chavada R; Hui SH; O'Connor S; Akima S; Gosbell IB
Med J Aust; 2015 Nov; 203(9):364. PubMed ID: 26510804
[No Abstract] [Full Text] [Related]
27. Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications.
Roussel C; Caumes E; Thellier M; Ndour PA; Buffet PA; Jauréguiberry S
J Travel Med; 2017 Mar; 24(2):. PubMed ID: 28395097
[TBL] [Abstract][Full Text] [Related]
28. Increase hemoglobin level in severe malarial anemia while controlling parasitemia: A mathematical model.
Siewe N; Friedman A
Math Biosci; 2020 Aug; 326():108374. PubMed ID: 32416085
[TBL] [Abstract][Full Text] [Related]
29. [Haemolysis: role of the direct antiglobulin test and eluate].
Hamer HM; Beckers EA; Henskens YM
Ned Tijdschr Geneeskd; 2018; 161():D1290. PubMed ID: 29350115
[TBL] [Abstract][Full Text] [Related]
30. Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence.
Rehman K; Lötsch F; Kremsner PG; Ramharter M
Int J Infect Dis; 2014 Dec; 29():268-73. PubMed ID: 25448338
[TBL] [Abstract][Full Text] [Related]
31. [Malaria treatment with artesunate (retocaps) in children of the Brazilian Amazon].
Alecrim MG; Carvalho LM; Fernandes MC; de Andrade SD; Loureiro AC; Arcanjo AR; Alecrim WD
Rev Soc Bras Med Trop; 2000; 33(2):163-8. PubMed ID: 10881128
[TBL] [Abstract][Full Text] [Related]
32. Artesunate-induced hemolysis in severe complicated malaria - A diagnostic challenge: A case report and literature review of anemia in malaria.
Sardar S; Abdurabu M; Abdelhadi A; Habib MB; Jamshaid MB; Hajjar AH; Abu Ageila M; Abdalla T; Kartha A; Farooqui K
IDCases; 2021; 25():e01234. PubMed ID: 34377668
[TBL] [Abstract][Full Text] [Related]
33. Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.
Charles M; Patterson JM; Asadi L; Houston S
Am J Trop Med Hyg; 2015 Oct; 93(4):819-21. PubMed ID: 26240154
[TBL] [Abstract][Full Text] [Related]
34. Evidence against immune haemolysis in falciparum malaria in Thailand.
Merry AH; Looareesuwan S; Phillips RE; Chanthavanich P; Supanaranond W; Warrell DA; Weatherall DJ
Br J Haematol; 1986 Sep; 64(1):187-94. PubMed ID: 3530315
[TBL] [Abstract][Full Text] [Related]
35. Returned traveller presenting with anaemia: clinical challenge of post-artesunate delayed haemolysis.
Matsee W; Hiranrusme T; Pisutsan P; Hanboonkunupakarn B; Chotivanich K
J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34672351
[No Abstract] [Full Text] [Related]
36. Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens.
Smithuis F; van der Broek I; Katterman N; Kyaw MK; Brockman A; Lwin S; White NJ
Trans R Soc Trop Med Hyg; 2004 Mar; 98(3):182-92. PubMed ID: 15024929
[TBL] [Abstract][Full Text] [Related]
37. Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.
Karunajeewa HA; Kemiki A; Alpers MP; Lorry K; Batty KT; Ilett KF; Davis TM
Pediatr Infect Dis J; 2003 Mar; 22(3):251-6. PubMed ID: 12634587
[TBL] [Abstract][Full Text] [Related]
38. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
Abdallah TM; Elmardi KA; Elhassan AH; Omer MB; Elhag MS; Desogi MA; Siddig MF; Adam I
J Infect Dev Ctries; 2014 May; 8(5):611-5. PubMed ID: 24820465
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
Ukah M; Badejoko O; Ogunniyi S; Loto O; Aboderin O; Fatusi A
Int J Gynaecol Obstet; 2015 Oct; 131(1):41-4. PubMed ID: 26169336
[TBL] [Abstract][Full Text] [Related]
40. Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.
Tsuchido Y; Nakamura-Uchiyama F; Toyoda K; Iwagami M; Tochitani K; Shinohara K; Hishiya N; Ogawa T; Uno K; Kasahara K; Ouji Y; Kano S; Mikasa K; Shimizu T; Yoshikawa M; Maruyama H
Am J Trop Med Hyg; 2017 May; 96(5):1185-1189. PubMed ID: 28193740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
